These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 875632)

  • 21. Role of prolactin in lactation-induced changes in brown adipose tissue.
    Chan E; Swaminathan R
    Am J Physiol; 1990 Jan; 258(1 Pt 2):R51-6. PubMed ID: 2301647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Serum prolactin levels during sleep and in metoclopramide stimulation in normoprolactinemic anovulation and ovulation induction with bromocriptine].
    Suginami H; Ito T; Hamada K; Yano K; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):728-34. PubMed ID: 3722953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of bromocriptine and metoclopramide on serum prolactin levels in patients with amyotrophic lateral sclerosis.
    Szulc-Kuberska J; Stepień H; Klimek A; Cieślak D
    J Neurol Neurosurg Psychiatry; 1988 May; 51(5):643-5. PubMed ID: 3404163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin secretion during pregnancy and puerperium: response to metoclopramide and interactions with placental hormones.
    Bohnet HG; Kato K
    Obstet Gynecol; 1985 Jun; 65(6):789-92. PubMed ID: 3839061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological difference of L-dopa, apomorphine, and bromocriptine against metoclopramide.
    Fang VS
    Life Sci; 1981 May; 28(19):2143-9. PubMed ID: 7253807
    [No Abstract]   [Full Text] [Related]  

  • 26. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    J Pharmacol Exp Ther; 1984 Feb; 228(2):370-5. PubMed ID: 6363675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Increased secretion of prolactin after inhibition of dopaminergic receptors by metoclopramide in patients with cancer of the prostate].
    Baranowska B; Jeske W; Szymanowski J; Piechna K
    J Urol (Paris); 1983; 89(8):601-5. PubMed ID: 6203986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes of CSF prolactin induced by metoclopramide in man.
    Perria C; Siani C; Barreca T; Francaviglia N; Magnani G; Zattoni I; Bottaro L; Marabini A; Rolandi E
    J Neurosurg Sci; 1983; 27(4):233-6. PubMed ID: 6674419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prolactin-releasing system in maternal, fetal, and amniotic compartments during labor.
    Kubota T; Nagae M; Yaoi Y; Kumasaka T; Saito M
    Obstet Gynecol; 1986 Jul; 68(1):80-5. PubMed ID: 3725261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analgesic effect of metoclopramide and its mechanism.
    Ramaswamy S; Bapna JS
    Life Sci; 1986 Apr; 38(14):1289-92. PubMed ID: 3959754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metoclopramide stimulates prolactin secretion in man.
    McCallum RW; Sowers JR; Hershman JM; Sturdevant RA
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1148-52. PubMed ID: 777023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of estrogen receptors with drugs that affect prolactin secretion.
    Liel Y; Marbach M; Aflalo L; Glick SM; Levy J
    Biochem Pharmacol; 1982 Mar; 31(5):707-10. PubMed ID: 7082339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ascorbic acid on pituitary prolactin secretion in the non-ascorbate synthesizing Osteogenic Disorder Shionogi (ODS) rat.
    Kawaguchi M; Hayakawa F; Kamiya Y; Fujii T; Ito J; Sakuma N; Fujinami T
    Life Sci; 1993; 52(11):975-9. PubMed ID: 8445988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical aspects of the sensitivity of the prolactin system to daily fluctuation].
    Rindt W; Lücker PW; Treitz P; Bitsch M
    Methods Find Exp Clin Pharmacol; 1981; 3 Suppl 1():115S-118S. PubMed ID: 7321655
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolactin and growth hormone dynamics in epileptic patients receiving phenytoin.
    Elwes RD; Dellaportas C; Reynolds EH; Robinson W; Butt WR; London DR
    Clin Endocrinol (Oxf); 1985 Sep; 23(3):263-70. PubMed ID: 4075538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tests of prolactin secretion in diagnosis of prolactinomas.
    Cowden EA; Ratcliffe JG; Thomson JA; Macpherson P; Doyle D; Teasdale GM
    Lancet; 1979 Jun; 1(8127):1155-8. PubMed ID: 86882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of drug-induced hyper- and hypoprolactinemia on human corpus luteum.
    Garcea N; Campo S; Siccardi P; Panetta V; Venneri M; Dargenio R
    Acta Eur Fertil; 1983; 14(1):35-40. PubMed ID: 6326451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperprolactinemia associated with chronic renal failure in the rat.
    Torres-Noriega J; Frohman LA
    Horm Metab Res; 1986 Apr; 18(4):241-3. PubMed ID: 3710420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.